Old Web
English
Sign In
Acemap
>
authorDetail
>
Driss Rochdi
Driss Rochdi
Indacaterol
Physical therapy
COPD
Medicine
Salmeterol fluticasone
3
Papers
7
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The burden of illness of Migraine in Canada: New insights on humanistic and economic cost.
2021
Canadian Journal of Neurological Sciences
Farnaz Amoozegar
Zaeem Khan
Mariana Oviedo Ovando
Stephanie Sauriol
Driss Rochdi
Show All
Source
Cite
Save
Citations (0)
Real-life effectiveness of indacaterol–glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study
2019
International Journal of Chronic Obstructive Pulmonary Disease
Alan Kaplan
Kenneth R. Chapman
Syed M Anees
Irvin Mayers
Driss Rochdi
Michel Djandji
David Préfontaine
Andrew McIvor
Show All
Source
Cite
Save
Citations (7)
Health status changes in COPD patients after real-life switch from tiotropium or salmeterol/fluticasone to indacaterol/glycopyrronium using the EQ-5D-3L instrument: results from the POWER study
2018
European Respiratory Journal
Syed Anees
Andrew McIvor
Kenneth R. Chapman
Irvin Mayers
Driss Rochdi
David Préfontaine
Alan Kaplan
Show All
Source
Cite
Save
Citations (0)
1